Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 8:8:721845.
doi: 10.3389/fvets.2021.721845. eCollection 2021.

Cystatin C and Iris: Advances in the Evaluation of Kidney Function in Critically Ill Dog

Affiliations

Cystatin C and Iris: Advances in the Evaluation of Kidney Function in Critically Ill Dog

Fabiola de Oliveira Paes-Leme et al. Front Vet Sci. .

Abstract

Critically ill hospitalized dogs are subject to certain complications, being acute kidney injury (AKI) a common one. Early diagnosis is crucial, and Cystatin C (CysC) is a reliable and early biomarker. The International Society of Renal Interest (IRIS) states that AKI severity can be assessed by mild changes in creatinine serum levels or reduction of urine output that cannot be considered biomarkers of renal injury but failure or insufficiency. Twenty-eight dogs admitted to the Intensive Care Unit under risk factors for the development of AKI were evaluated. Blood samples were collected for determination of sCr and CysC at admission and after 24, 48, and 72 h. Urine output was measured by daily monitoring, measured by collection in a closed system. The results showed the incidence of AKI was 67.9% based on the IRIS criteria and 78.6% based on cystatin C in critically ill patients' dogs. The measurement of serum cystatin C immediately on admission to the ICU was superior in the early identification of patients with AKI when compared to the IRIS classification and serum creatinine in critically ill dogs.

Keywords: creatinine; cystatin C; dogs; failure; illness; insufficiency; kidney.

PubMed Disclaimer

Conflict of interest statement

PV was employed by company Labtest Diagnóstica S.A. MA was employed by company Enzytec, Biotecnologia Ltda. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. . Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. (2011) 37:241–8. 10.1007/s00134-010-2089-9 - DOI - PMC - PubMed
    1. Mugford A, Li R, Humm K. Acute kidney injury in dogs and cats 1. Pathogenesis and diagnosis. In Pract. (2013) 35:253–64. 10.1136/inp.f2868 - DOI
    1. Miyagawa Y, Takemura N, Hirose H. Assessments of factors that affect glomerular filtration rate and indirect markers of renal function in dogs and cats. J Vet Med Sci. (2010) 72:1129–36. 10.1292/jvms.09-0443 - DOI - PubMed
    1. Ghys L, Paepe D, Smets P, Lefebvre H, Delanghe J, Daminet S. Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med. (2014) 28:1152–64. 10.1111/jvim.12366 - DOI - PMC - PubMed
    1. Von Hendy-Willson VE, Pressler BM. An overview of glomerular filtration rate testing in dogs and cats. Vet J. (2011) 188:156–65. 10.1016/j.tvjl.2010.05.006 - DOI - PMC - PubMed